Core Laboratories - CLB Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last twelve months. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "sell" CLB shares.
View CLB analyst ratings or view top-rated stocks.

3 analysts have issued 12 month price objectives for Core Laboratories' shares. Their CLB share price forecasts range from $17.00 to $21.30. On average, they anticipate the company's share price to reach $19.58 in the next twelve months. This suggests a possible upside of 4.6% from the stock's current price.
View analysts price targets for CLB or view top-rated stocks among Wall Street analysts.

Core Laboratories' stock was trading at $22.31 at the start of the year. Since then, CLB shares have decreased by 16.1% and is now trading at $18.72.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our CLB earnings forecast.

Core Laboratories (NYSE:CLB) released its earnings results on Wednesday, October, 26th. The oil and gas company reported $0.18 earnings per share for the quarter, beating analysts' consensus estimates of $0.09 by $0.09. The oil and gas company had revenue of $125.97 million for the quarter, compared to analysts' expectations of $126.14 million. Core Laboratories had a trailing twelve-month return on equity of 15.71% and a net margin of 3.16%.

Core Laboratories announced a quarterly dividend on Wednesday, October 26th. Shareholders of record on Monday, November 7th will be given a dividend of $0.01 per share on Monday, November 28th. This represents a $0.04 annualized dividend and a yield of 0.21%. The ex-dividend date of this dividend is Friday, November 4th.
Read our dividend analysis for CLB.

Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.20%. The dividend payout ratio is 12.12%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 4.55% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLB.

Core Laboratories issued an update on its fourth quarter 2022 earnings guidance on Wednesday, November, 2nd. The company provided EPS guidance of $0.17-$0.21 for the period, compared to the consensus EPS estimate of $0.17. The company issued revenue guidance of $126.00 million-$131.00 million, compared to the consensus revenue estimate of $129.98 million.

60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.01%), Vanguard Group Inc. (11.09%), Fred Alger Management LLC (8.82%), Boston Trust Walden Corp (4.34%), State Street Corp (2.81%) and Van ECK Associates Corp (2.67%). Insiders that own company stock include Jan Willem Sodderland, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends.

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLB stock can currently be purchased for approximately $18.72.

Core Laboratories (NYSE:CLB) has a market capitalization of $868.05 million and generates $470.25 million in revenue each year. The oil and gas company earns $19.73 million in net income (profit) each year or $0.33 on an earnings per share basis.

The company employs 3,700 workers across the globe.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for the company is www.corelab.com. The oil and gas company can be reached via phone at (120) 420-3191 or via email at investor.relations@corelab.com.